跳至主要内容
临床试验/ACTRN12624000916549
ACTRN12624000916549尚未招募Unknown

Investigating a novel therapeutic diet on food additives for ulcerative colitis in adults - The INNOVATE Study

Alfred Health0 个研究点目标入组 32 人开始时间: 2024年7月29日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
Alfred Health
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • mild to moderate ulcerative colitis
  • - active disease (either left-sided or extensive UC) as evidenced sonographically, faecal calprotectin >250 and where available, endoscopy results performed in the last 3 months indicate total Mayo score of 3-10
  • - on stable medical therapy for >1 month
  • - naïve to formal dietetic intervention

排除标准

  • - Severe UC, indeterminate colitis or Crohn’s disease
  • - Presence of other GI co-morbidities (e.g. coeliac disease)
  • - Presence of clinically significant haematological abnormalities
  • - Prior gastrointestinal surgeries
  • - Pregnancy, trying to get pregnant and breastfeeding
  • - Current use of corticosteroids
  • - Dietary restrictions, food allergies, intolerances or aversions, that would interfere with consuming intervention foods (e.g. food allergy, veganism, lacto-ovo vegetarianism)
  • - Individuals not on a stable diet for at least 4 weeks

研究者

发起方
Alfred Health

相似试验